CD33 and neoplasm: For example, the strategy of constructing dual-target CAR in series or parallel to overcome the escape of antigen, Knock out CD33, etc., in targeted blood tumor treatment, or use gene mechanism and other designs in solid tumor treatment to solve the non-target Off-Tumor toxicity.